Background
Macadamia nut, namely hawaii nut, is a nut plant native to the macadamia, has high economic value, good nutritional value and medicinal value, and is a reputation of 'king dried fruits'. The macadimia nut has more diseases and insect pests, more than 30 diseases and more than 300 insect pests, and the diseases are damping off, root rot, flower blight, anthracnose, ulceration and gray mold. Wherein anthracnose mainly damages leaves, tender tips and fruits of macadimia nuts, and is characterized in that the tender tips of the macadimia nuts are dead, the tender leaves of the macadimia nuts are yellow, black plaques appear on the surfaces of the tender tips, and young fruits and shells of the macadimia nuts are black brown and gradually develop into black conidium devices, so that the yield and quality of the macadimia nuts are affected. The chemical agent is a common means for preventing and controlling anthracnose, but the anthracnose can generate drug resistance after long-term application of a single chemical agent, and at present, the anthracnose generates different degrees of drug resistance to the existing chemical agent, so that fruit farmers usually increase the application dosage of the chemical agent to improve the prevention and control effect, the generation of drug resistance is accelerated, and meanwhile, the problem of pesticide residues is also caused.
Wang Xuelian, li MinminAnd the like, the inhibition effect of 18 coumarin compounds on citrus anthracnose is measured by adopting a growth rate method, and the fact that the isocoumarin compound bergenin has the strongest inhibition activity on citrus anthracnose is found, and EC 50 Is 7.2766 mug/mL. Therefore, the bergenia lactone can be utilized to effectively prevent anthracnose. As with the chemical agents, if the active ingredient is singly applied for a long time, the diseases are easy to generate drug resistance.
Compounding different pesticide effective components is an effective shortcut for developing new pesticide varieties. Three types of actions can be shown after the different pesticide active ingredients are compounded: addition, synergy and antagonism. The inventor discovers that when bergenin is binary compounded with pyraclostrobin, fluopyram or bromothalonil through a large number of experiments, the bergenin can show remarkable synergistic effect within a certain mass ratio range, and has important significance for protecting bergenin medicaments and delaying the drug resistance of diseases.
The information disclosed in this background section is only for enhancement of understanding of the general background of the invention and should not be taken as an acknowledgement or any form of suggestion that this information forms the prior art already known to a person of ordinary skill in the art.
Disclosure of Invention
The invention aims to provide a pesticide composition for preventing and treating anthracnose of macadimia nut, and aims to overcome the defect that diseases are easy to generate drug resistance due to single application of bergenin for a long time.
In order to achieve the aim, the invention provides a pesticide composition for preventing and treating anthracnose of macadimia nut, and the effective components of the pesticide composition are compounded by bergenin and bromothalonil.
Preferably, the mass ratio of bergenin to bromothalonil is 1-40:40-1.
Compared with the prior art, the invention has the following beneficial effects:
when the pesticide composition for preventing and controlling the anthracnose of the macadimia nut is subjected to binary compounding, the synergistic effect is obvious, and compared with a single agent, the pesticide composition for preventing and controlling the anthracnose of the macadimia nut has the advantages that the application dosage and times of pesticides can be reduced, the prevention and control cost is reduced, and the pesticide residue of the macadimia nut is reduced.
The pesticide composition for preventing and treating the anthracnose of the macadimia nut is prepared by compounding two effective components, can delay the generation of drug resistance of the anthracnose of the macadimia nut to the compound drug, reduces the risk caused by independently applying bergenin, and can play a certain role in protecting the bergenin.
Detailed Description
The following detailed description of specific embodiments of the invention is, but it should be understood that the invention is not limited to specific embodiments.
Examples: indoor biological activity test of bergenia lactone compound
Test agent: 98.8% bergenin crude drug, 98% pyraclostrobin crude drug, 96% fluopyram crude drug and 95% bromothalonil crude drug
Test pathogen: the pathogen of macadimia nut anthracnose is collected from the disease incidence part of the macadimia nut anthracnose, and is separated and purified in a laboratory
The test method comprises the following steps: reference to section 2 of the pesticide "NY/T1156.2-2006 indoor bioassay test guidelines for pesticides: test Petri dish method for inhibiting growth of pathogenic fungi hyphae
1. Dissolving the original medicine with ethanol, diluting with 0.1% Tween-80 to prepare single-dose mother solution, setting multiple groups of proportions, and setting multiple gradient mass concentrations of each single dose and each group of proportions according to an equal ratio method for standby;
2. under aseptic condition, the pre-melted PDA culture medium is quantitatively added into an aseptic conical flask, the liquid medicine is quantitatively sucked from low concentration to high concentration sequentially, and the liquid medicine is respectively added into the conical flask and fully shaken. Then, the mixture was poured into 4 dishes of 9cm diameter in equal amounts to prepare medicated plates, and a blank treatment containing only ethanol and 0.1% Tween-80 was applied, each treatment being repeated 3 times.
3. Under the aseptic condition, a sterilizing puncher with the diameter of 5mm is used for punching holes on the edges of the pathogen colonies of the macadimia nut anthracnose to prepare a bacterial cake with the diameter of 5 mm; the bacterial cake is inoculated in the center of the drug-containing flat plate by an inoculator, the mycelium surface faces upwards, and the bacterial cake is placed in an incubator at 25 ℃ for culture after the dish cover is covered.
4. When the diameter of the blank control colony reaches more than 2/3 of the diameter of the culture dish, the diameter of the colony is measured by a caliper, the diameter of each colony is measured vertically by a crisscross method, the average value of the colony is taken, the growth inhibition rate of hyphae of each treatment is calculated, regression analysis is carried out on the numerical value of the concentration of the medicament and the growth inhibition rate value of the hyphae by DPS software, the EC50 of each treatment medicament is calculated, and the co-toxicity coefficient (CTC value) of the mixed medicament is calculated according to a Sun Yunpei method.
Hypha growth inhibition (%) = [ (control colony diameter-5) - (agent-treated colony diameter-5) ]/[ (control colony diameter-5) ]100;
measured virulence index (ATI) = (standard agent EC 50/test agent EC 50) ×100;
theoretical Toxicity Index (TTI) =a agent toxicity index x percentage of agent toxicity index in mixture + B agent toxicity index x percentage of agent toxicity in mixture;
co-toxicity coefficient (CTC) = [ actual drug susceptibility index (ATI)/theoretical drug susceptibility index (TTI) ] x 100.
Dividing the standard according to the joint action:
the co-toxicity coefficient (CTC) is more than or equal to 120, and the synergistic effect is shown;
the cotoxicity coefficient (CTC) is less than or equal to 80 and shows antagonism;
80< co-toxicity coefficient (CTC) <120 shows additive effect.
The experimental results are shown in tables 1-3.
TABLE 1 indoor biological Activity determination of bergenin and pyraclostrobin Complex against Australian nut anthracnose pathogen
Medicament name and ratio
|
EC50(mg/L)
|
ATI
|
TTI
|
CTC
|
Bergenia lactone
|
9.84
|
100
|
--
|
--
|
Pyraclostrobin
|
4.43
|
222.12
|
--
|
--
|
Bergenia crassifolia lactone 1: pyraclostrobin 20
|
3.43
|
286.88
|
216.31
|
132.63
|
Bergenia crassifolia lactone 1: pyraclostrobin 16
|
3.17
|
310.41
|
214.94
|
144.42
|
Bergenia crassifolia lactone 1: pyraclostrobin 12
|
2.94
|
334.69
|
212.73
|
157.33
|
Bergenia crassifolia lactone 1: pyraclostrobin 8
|
2.27
|
433.48
|
205.88
|
207.85
|
Bergenia crassifolia lactone 1: pyraclostrobin 4
|
1.93
|
509.84
|
197.70
|
257.89
|
Bergenia crassifolia lactone 1: pyraclostrobin 1
|
1.66
|
592.77
|
161.06
|
368.04
|
Bergenia crassifolia lactone 2: pyraclostrobin 1
|
4.83
|
203.73
|
140.71
|
144.79
|
Bergenia crassifolia lactone 4: pyraclostrobin 1
|
5.92
|
166.22
|
124.42
|
133.59
|
Bergenia crassifolia lactone 6: pyraclostrobin 1
|
3.17
|
310.41
|
117.45
|
264.30
|
Bergenia crassifolia lactone 8: pyraclostrobin 1
|
2.88
|
341.67
|
113.57
|
300.84
|
Bergenia crassifolia lactone 10: pyraclostrobin 1
|
4.17
|
235.97
|
111.10
|
212.39 |
From table 1, it can be seen that the mass ratio of bergenin to pyraclostrobin is 1-10: the co-toxicity coefficient of the total toxicity to the pathogen of the macadimia nut anthracnose is more than 120 in the range of 20-1, and the synergy is obvious.
TABLE 2 indoor biological Activity determination of bergenin and Fluopyram Complex against Australian nut anthracnose pathogen
Medicament name and ratio
|
EC50(mg/L)
|
ATI
|
TTI
|
CTC
|
Bergenia lactone
|
9.84
|
100.00
|
--
|
--
|
Fluopicolide
|
3.29
|
299.09
|
--
|
--
|
Bergenia crassifolia lactone 1: fluopicolide 15
|
1.93
|
509.84
|
286.65
|
177.87
|
Bergenia crassifolia lactone 1: fluopicolide 12
|
1.85
|
531.89
|
283.77
|
187.44
|
Bergenia crassifolia lactone 1: fluopicolide 9
|
1.66
|
592.77
|
279.18
|
212.33
|
Bergenia crassifolia lactone 1: fluopicolide 7
|
1.53
|
643.14
|
274.20
|
234.55
|
Bergenia crassifolia lactone 1: fluopicolide 5
|
1.35
|
728.89
|
265.91
|
274.11
|
Bergenia crassifolia lactone 1: fluopicolide 3
|
1.19
|
826.89
|
249.32
|
331.66
|
Bergenia crassifolia lactone 1: fluopicolide 1
|
2.83
|
347.70
|
199.54
|
174.25
|
Bergenia crassifolia lactone 5: fluopicolide 1
|
3.91
|
251.66
|
133.18
|
188.96
|
Bergenia crassifolia lactone 10: fluopicolide 1
|
4.22
|
233.18
|
118.10
|
197.44
|
Bergenia crassifolia lactone 15: fluopicolide 1
|
5.51
|
178.58
|
112.44
|
158.82
|
Bergenia crassifolia lactone 20: fluopicolide 1
|
4.88
|
201.64
|
109.48
|
184.18
|
Bergenia crassifolia lactone 25: fluopicolide 1
|
3.46
|
284.39
|
107.66
|
264.17
|
Bergenia crassifolia lactone 30: fluopicolide 1
|
4.42
|
222.62
|
106.42
|
209.19 |
As can be seen from table 2, the bergenin and fluopyram of the invention are compounded in a mass ratio of 1-30: the co-toxicity coefficient of the macadimia nut anthracnose pathogenic bacteria is more than 120 in the range of 15-1, and the synergy is obvious.
TABLE 3 indoor biological Activity determination of bergenin and bromothalonil Complex against Australian nut anthracnose pathogen
Medicament name and ratio
|
EC50(mg/L)
|
ATI
|
TTI
|
CTC
|
Bergenia lactone
|
9.84
|
100.00
|
--
|
--
|
Bromothalonil
|
4.86
|
202.47
|
--
|
--
|
Bergenia crassifolia lactone 1: bromothalonil 40
|
3.47
|
283.57
|
199.97
|
141.81
|
Bergenia crassifolia lactone 1: bromothalonil 30
|
2.84
|
346.48
|
199.16
|
173.97
|
Bergenia crassifolia lactone 1: bromothalonil 20
|
2.13
|
461.97
|
197.59
|
233.80
|
Bergenia crassifolia lactone 1: bromothalonil 15
|
1.68
|
585.71
|
196.06
|
298.74
|
Bergenia crassifolia lactone 1: bromothalonil 10
|
2.46
|
400.00
|
193.15
|
207.09
|
Bergenia crassifolia lactone 1: bromothalonil 5
|
2.21
|
445.25
|
185.39
|
240.17
|
Bergenia crassifolia lactone 1: bromothalonil 1
|
1.20
|
820.00
|
151.23
|
542.20
|
Bergenia crassifolia lactone 5: bromothalonil 1
|
2.92
|
336.99
|
117.08
|
287.83
|
Bergenia crassifolia lactone 10: bromothalonil 1
|
3.69
|
266.67
|
109.32
|
243.94
|
Bergenia crassifolia lactone 15: bromothalonil 1
|
4.39
|
224.15
|
106.40
|
210.65
|
Bergenia crassifolia lactone 20: bromothalonil 1
|
6.05
|
162.64
|
104.88
|
155.08
|
Bergenia crassifolia lactone 30: bromothalonil 1
|
7.12
|
138.20
|
103.31
|
133.78
|
Bergenia crassifolia lactone 40: bromothalonil 1
|
7.47
|
131.73
|
102.50
|
128.52 |
As can be seen from Table 3, the bergenin and bromothalonil are compounded in a mass ratio of 1-40: the co-toxicity coefficient of the drug to the pathogen of the macadimia nut anthracnose is more than 120 in the range of 40-1, and the synergistic effect is obvious.
From tables 1-3, it can be seen that bergenin, pyraclostrobin, fluopyram or bromothalonil in the invention shows synergistic effect on macadimia nut anthracnose within a certain mass ratio range after being compounded.
The exemplary embodiments were chosen and described in order to explain the specific principles of the invention and its practical application to thereby enable one skilled in the art to make and utilize the invention in various exemplary embodiments and with various modifications as are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the claims and their equivalents.